Christi Roush
Family · Hobe Sound, FLNPI 1154864304
Payments from drug & device makers
Across 124 payments — averaging $17.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$489
- AstraZeneca$267
- Pfizer$188
- Boehringer Ingelheim$142
- Astellas Pharma US Inc$140
- Lilly USA, LLC$137
- plus $828 from 19 others
What the payments were for
- Food & beverage$2,191100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 38 | $489 |
| AstraZeneca | 8 | $267 |
| Pfizer | 13 | $188 |
| Boehringer Ingelheim | 6 | $142 |
| Astellas Pharma US Inc | 2 | $140 |
| Lilly USA, LLC | 9 | $137 |
| Amgen | 9 | $133 |
| Novo Nordisk | 8 | $129 |
| Idorsia Pharmaceuticals US Inc | 2 | $122 |
| Merck | 5 | $66 |
| GSK | 3 | $46 |
| Nestle Healthcare Nutrition Inc. | 3 | $44 |
| Bayer | 3 | $42 |
| Alkermes, Inc. | 2 | $38 |
| Sunovion Pharmaceuticals Inc. | 2 | $31 |
| Corium, LLC | 2 | $28 |
| Hologic Sales And Service, LLC | 1 | $22 |
| Kyowa Kirin, Inc. | 1 | $19 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $18 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $16 |
| Johnson & Johnson | 1 | $16 |
| Exact Sciences | 1 | $15 |
| Teva Pharmaceuticals USA, Inc. | 1 | $15 |
| Sanofi-aventis U.S. LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,191 in reported general payments places this provider in the 80th percentile of 14,618 family providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 62 | $61,914 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 17 | $22,045 |
| EliquisApixaban | 13 | $8,009 |
| BrilintaTicagrelor | 11 | $5,501 |
| SynthroidLevothyroxine Sodium | 27 | $2,967 |
| Liothyronine Sodium | 48 | $2,245 |
| Levothyroxine Sodium | 119 | $1,504 |
| Estradiol (Twice Weekly)Estradiol | 20 | $1,013 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 32 | $800 |
| Omeprazole | 66 | $784 |
| Duloxetine Hcl | 30 | $681 |
| Gabapentin | 41 | $671 |
| Losartan Potassium | 58 | $631 |
| Metoprolol Succinate | 43 | $615 |
| Amlodipine Besylate | 100 | $597 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $129 | $61,91462 claims |
| GSKTrelegy Ellipta | $46 | $22,04517 claims |
| PfizerEliquis | $188 | $8,00913 claims |
| AstraZenecaBrilinta | $267 | $5,50111 claims |
| AbbVieSynthroid | $489 | $2,96727 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 14,618 family providers in Florida.
Other family in Hobe Sound
- John HuffakerVenice$8M
- Stephanie MompointMiami$4.5M
- Miguel TrujilloMiami Gardens$4.4M
- Itsel Cardenas RamonMiami$1M
- Lewis HarringtonTampa$954K
- Adam StrosbergFort Lauderdale$859K
- Danielle PharesFt Lauderdale$713K
- David RodriguezHialeah$658K
- Donna OrtizOrlando$417K
- Patrick SzarazMiami$327K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.